Episode Details
Back to Episodes
Episode 480: ASCO GU 2026 - PEACE-3 and BRCAway Final OS Results
Published 7 months, 4 weeks ago
Description
In this episode, Evan Yu discusses the latest prostate cancer data presented at ASCO GU, focusing on the final overall survival results of the PEACE 3 trial, the implications of crossing survival curves, and the evolving role of radioligand therapy and PARP inhibitors in prostate cancer treatment.